Sectors > Top Reports > IVS Memo 200420
IVS Memo 200420
IVS. Flexible Costs & Strong Liquidity Make FY 20 Headwinds Manageable. Opportunistic Acquisitions To Drive Growth. M&A Provides A Put Option. Buy Equity At €6.0 & SUNs At €85
PUBLISHED: 20 April 2020
PAGES: 262
PRODUCT CODE: IVSIM001
SUBMARKET:
IVS, Top Reports, Top Reports,
£2,670.00
Why Read?
- Business analysis – segments, regions, clients, suppliers, substitutes, etc.
- Industry overview and comparable analysis versus, in particular, Selecta
- Industry regulation and key macro drivers
- Understand EBITDA and FCF potential
- Understand our base, bull and bear case projections under COVID-19
- Liquidity and deleveraging potential
- Valuation – DCF
- Analysis of the capital structure and legal documentation of each debt instrument and bond pricing
- Waterfall analysis and expected recovery rates on IVS’ Senior Unsecured Notes (SUNs)
What’s New?
- COVID-19 impact on IVS
Questions Answered
- What are the likely impacts of COVID-19 on the business and its financial performance?
- Under what circumstances would liquidity break?
- Will the business be able to deleverage post the COVID-19 shock to the extent needed to refinance?
- What recovery can be expected on the SUNs?